Table 1. Cell line panel.
| Catalog # | Tumor cell line | Source |
|---|---|---|
| Lung cancer | ||
| CCL-185 | A549 | LGC |
| CRL-5908 | NCI-H1975 | LGC |
| CRL-5909 | NCI-H1993 | LGC |
| CRL-5800 | NCI-H23 | LGC |
| CRL-5807 | NCI-H358 | LGC |
| HTB-177 | NCI-H460 | LGC |
| CRL-5810 | NCI-H522 | LGC |
| HTB-178 | NCI-H596 | LGC |
| Breast cancer | ||
| HTB-19 | BT20 | LGC |
| HTB-20 | BT474 | LGC |
| HTB-22 | MCF7 | LGC |
| HTB-26 | MDAMB231 | LGC |
| HTB-131 | MDAMB453 | LGC |
| HTB-132 | MDAMB468 | LGC |
| HTB-30 | SKBR3 | LGC |
| JIMT1 | DSMZ | |
| KPL4 | DSMZ | |
| Pancreatic cancer | ||
| CRL-1687 | BxPc3 | LGC |
| CRL-1469 | Panc1 | LGC |
| HTB-79 | Capan1 | LGC |
| HTB-80 | Capan2 | LGC |
| CRL-2119 | HPAC | LGC |
| CRL-1682 | AsPc1 | LGC |
| PK45P | Oncotherapy Science, Inc. | |
| Suit2 | Oncotherapy Science, Inc. | |
| PancTu-1 | DSMZ | |
| Fibroblasts | ||
| PC60161A (primary breast TAFs) | 161A | Asterand, PLC. |
| PC60129A1(primary lung TAFs) | 129A | Asterand, PLC. |
| CCL-171 | MRC5 | ATCC |
| SCR013 | LT2 | Millipore corporation |